Synopsis
0
CEP/COS
0
VMF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Capital Farma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Chewable & Orodispersible Aids
Taste Masking
Direct Compression
Disintegrants & Superdisintegrants
Co-Processed Excipients
Parenteral
Granulation
Thickeners and Stabilizers
Solubilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
78
PharmaCompass offers a list of Teriparatide Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Teriparatide Acetate manufacturer or Teriparatide Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Teriparatide Acetate manufacturer or Teriparatide Acetate supplier.
PharmaCompass also assists you with knowing the Teriparatide Acetate API Price utilized in the formulation of products. Teriparatide Acetate API Price is not always fixed or binding as the Teriparatide Acetate Price is obtained through a variety of data sources. The Teriparatide Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Forteo manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Forteo, including repackagers and relabelers. The FDA regulates Forteo manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Forteo API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Forteo manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Forteo supplier is an individual or a company that provides Forteo active pharmaceutical ingredient (API) or Forteo finished formulations upon request. The Forteo suppliers may include Forteo API manufacturers, exporters, distributors and traders.
click here to find a list of Forteo suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Forteo DMF (Drug Master File) is a document detailing the whole manufacturing process of Forteo active pharmaceutical ingredient (API) in detail. Different forms of Forteo DMFs exist exist since differing nations have different regulations, such as Forteo USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Forteo DMF submitted to regulatory agencies in the US is known as a USDMF. Forteo USDMF includes data on Forteo's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Forteo USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Forteo suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Forteo Drug Master File in Japan (Forteo JDMF) empowers Forteo API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Forteo JDMF during the approval evaluation for pharmaceutical products. At the time of Forteo JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Forteo suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Forteo Drug Master File in Korea (Forteo KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Forteo. The MFDS reviews the Forteo KDMF as part of the drug registration process and uses the information provided in the Forteo KDMF to evaluate the safety and efficacy of the drug.
After submitting a Forteo KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Forteo API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Forteo suppliers with KDMF on PharmaCompass.
A Forteo written confirmation (Forteo WC) is an official document issued by a regulatory agency to a Forteo manufacturer, verifying that the manufacturing facility of a Forteo active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Forteo APIs or Forteo finished pharmaceutical products to another nation, regulatory agencies frequently require a Forteo WC (written confirmation) as part of the regulatory process.
click here to find a list of Forteo suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Forteo as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Forteo API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Forteo as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Forteo and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Forteo NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Forteo suppliers with NDC on PharmaCompass.
Forteo Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Forteo GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Forteo GMP manufacturer or Forteo GMP API supplier for your needs.
A Forteo CoA (Certificate of Analysis) is a formal document that attests to Forteo's compliance with Forteo specifications and serves as a tool for batch-level quality control.
Forteo CoA mostly includes findings from lab analyses of a specific batch. For each Forteo CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Forteo may be tested according to a variety of international standards, such as European Pharmacopoeia (Forteo EP), Forteo JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Forteo USP).
